Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Number of holders
-
278
-
Total 13F shares, excl. options
-
40,965,872
-
Shares change
-
+42,564
-
Total reported value, excl. options
-
$3,292,084,415
-
Value change
-
-$3,371,001
-
Put/Call ratio
-
146%
-
Number of buys
-
117
-
Number of sells
-
134
-
Price
-
$80.36
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q2 2024
As of 30 Jun 2024 BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) had 353 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 40,965,872 shares of stock of the company.
Largest 10 holders included BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, FLOSSBACH VON STORCH AG, HARDING LOEVNER LP, BlackRock Inc., Temasek Holdings (Private) Ltd, MORGAN STANLEY, Capital World Investors, Capital International Investors, and FMR LLC.
This table shows 353 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.